1,2-Dichloroethane → 1-Cyclopentyl-4-[1-tert-butoxycarbonyl-piperidine-4-carbonyl]-piperazine
Reaction equation
[C:1]([O:5][C:6]([N:8]1[CH2:13][CH2:12][CH:11]([C:14]([OH:16])=O)[CH2:10][CH2:9]1)=[O:7])([CH3:4])([CH3:3])[CH3:2].C(Cl)CCl.C1C=NC2N(O)N=NC=2C=1.[CH:31]1([N:36]2[CH2:41][CH2:40][NH:39][CH2:38][CH2:37]2)[CH2:35][CH2:34][CH2:33][CH2:32]1>CN(C=O)C>[CH:31]1([N:36]2[CH2:37][CH2:38][N:39]([C:14]([CH:11]3[CH2:10][CH2:9][N:8]([C:6]([O:5][C:1]([CH3:2])([CH3:3])[CH3:4])=[O:7])[CH2:13][CH2:12]3)=[O:16])[CH2:40][CH2:41]2)[CH2:32][CH2:33][CH2:34][CH2:35]1Participants
6
Reactant 4
Product 1
Reagents, catalysts & solvents 1
Procedure
1-tert-Butoxycarbonyl-piperidine-4-carboxylic acid (2.2 g) in dry DMF (40 ml) was treated with EDC (3.71 g) followed by HOAT (0.1 g). After 5 min, N-cyclopentylpiperazine (1.5 g) in dry DMF (5 ml) was added and the reaction mixture was stirred at rt for 18 h. Excess DMF was removed by evaporation and the resulting residue was re-dissolved in DCM, adsorbed onto silica gel (10 g) and purified by chromatography [silica gel 0-10% MeOH (containing 10% 0.88 ammonia solution/DCM)]. The pure fractions were combined and the solvent removed by evaporation to give the subtitled compound (2 g). LCMS electrospray(+ve) 366(MH+).
Workup
- customExcess DMF was removed by evaporation
- dissolutionthe resulting residue was re-dissolved in DCM
- custompurified by chromatography [silica gel 0-10% MeOH (containing 10% 0.88 ammonia solution/DCM)]
- customthe solvent removed by evaporation
Sources & evidence
- ORD record
- ord-0ec679d053724f9b9eb1eba83732442c
- Source dataset
- uspto-grants-2009_09
- Patent number
- US07592347B2
Reaction notes
Loading…